Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ)

Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ) — VMCI valuation read

The headline on Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ) is a 43/100 VMCI score, set against a Healthcare sector median of 50. That 7-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

002923.SZ insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** 002923.SZ trades at 23.0x earnings, 28% above the Healthcare median of 18.0x sets the value side. ROIC of 11.0% sits 1.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 2.1x is the rate-sensitivity line to watch sets the risk side, the three lines a value buyer reads first on 002923.SZ.

002923.SZ rose 1.3% over the trailing 7 days, with a -15.8% read on a 30-day basis.